Clinical therapeutic effect and biological monitoring of p53 gene in advanced hepatocellular carcinoma

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 37, Issue 1, 2014, Pages 24-29

  Chen, Shixi ^a   Chen, Jun ^a   Xi, Wei ^a   Xu, Weidong ^a   Yin, Guowen ^a  

^a Cancer Hospital   (China)

Author keywords

advanced hepatocellular carcinoma; biological monitoring; clinical observation; intervention; rAd p53 therapy

Indexed keywords

CAMPTOTHECIN; GENDICINE; PROTEIN P53; ANTINEOPLASTIC AGENT; HYDROXYCAMPTOTHECINUM;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BIOLOGICAL MONITORING; CATHETER; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; ILIAC ARTERY; LIVER CELL CARCINOMA; MALE; MICRONUCLEUS; MIDDLE AGED; SURVIVAL RATE; ANALOGS AND DERIVATIVES; ASCITES; CHEMOEMBOLIZATION; COMPLICATION; GENE THERAPY; GENETICS; INDWELLING CATHETER; INTRAARTERIAL DRUG ADMINISTRATION; KAPLAN MEIER METHOD; LIVER TUMOR; MORTALITY; PROCEDURES; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE;

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ASCITES; CAMPTOTHECIN; CARCINOMA, HEPATOCELLULAR; CATHETERS, INDWELLING; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; GENES, P53; GENETIC THERAPY; HUMANS; ILIAC ARTERY; INFUSIONS, INTRA-ARTERIAL; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84893764987     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181fe4688     Document Type: Article

References (15)

1. Xue W, Zender L, Miething C, et al. Senescence and tumor clearance is triggered by p53 restoration in murine liver carcinomas. Nature. 2007;445:656-660.
2. Atencio IA, Grace M, Bordens R, et al. Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a phase 1 colorectal cancer. Cancer Gene Ther. 2006;13:169-181.
3. Zheng X, Li H, Yongzhi Z, et al. Clinical Observation of Compound Matrine Injection Combined with Hydroxycamptothe-cin in treatment of advanced primary hepatocellular carcinoma. Chinese Clin Oncol. 2001;10:541-542.
4. Idogawa M, Sasaki Y, Suzuki H, et al. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells. Clin Cancer Res. 2009;15:3725-3732.
5. Guan YS, Liu Y, Sun L, et al. Links Successfully management of postoperative recurrence of hepatocellular carcinoma with p53 gene therapy combing transcatheter arterial chemoembolization. World J Gastroenterol. 2005;11:3803-3805.
6. Yang B-H, Xia J-l. Primary hepatocellular carcinoma diagnosis and staging criteria. Chinese J Hepatol. 2001;9:324.
7. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. JNCI. 2000;92:205-216
8. Radiology group of Chinese Journal of Radiology editorial board, Chinese Medical Association Chinese Journal Editorial Board Radiology Interventional. Standard Rule on interventional treatment for HCC (draft). Chinese J Radiol. 2001;35:887-891.
9. Xue KX, Xu L, Ma J-g, et al. Micronucleus formation in vivo in lymphocytes of human peripheral blood and individual susceptibility to lung cancer. Carcinogen Teratogen Mutagen. 2001;13:20-23.
10. Harris CC. Structure and functional of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J Natl Cancer Inst. 1996;88:1442-1455.
11. Beraza N, Trautwein C. Restoration of p53 function: a new therapeutic strategy to induce: tumor regression. Hepatology. 2007;45:1578-1579.
12. Hao Q, Tian J-m, Gao X-t, et al. The in vivo gene transfer efficacy and expression patterns by hepatic artery administration of recombinant adenovirus. Chinese J Radiol. 2000;34:662-665.
13. Guang-Yu Z, Qin L, Gao-Jun T, et al. Experimental research on treating hepatic carcinoma by arterial injection of liposome mediated p53 genes. J Intervent Radiol. 2000;34:662-665.
14. Guan Y-S, Liu Y, He Q, et al. Relationship between serum anti-P53 antibody and clinical characteristics of primary hepatic carcinoma. Shijie Huaren Xiaohua Zazhi. 2007;15:246-253.
15. Larmarcovai G, Botta A, Orsiere T. Micronuclei and genetic polymorphisms: from exposure to susceptibility. Ann Biol Clin. 2007;65:357-363.